Sign inJoin waitlistJoin the waitlist

Olatunji Alese

Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine · Emory University School of Medicine

Credentials: · · · ·

History

Emory University School of Medicine
Present

Hematology and Medical Oncology
Emory University School of Medicine
2012–2015
Metropolitan Hospital Center
2009–2012
University of Ibadan
2001–2008
UNIV OF IBADAN COLL OF MED, IBADAN, OYO STATE, NIGERIA
1996–2000

Research

A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract Cancer
JAMA Oncology · 2020 · 366 citations
Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms
Review · British Journal of Cancer · 2019 · 320 citations
Appendiceal Mucinous Neoplasms: Diagnosis and Management
Review · The Oncologist · 2017 · 176 citations

Bassel El-Rayes
60 papers
Christina Wu
44 papers
Walid Shaib
43 papers · 1 as a fellow
Mehmet Akce
38 papers
KZ
Katerina Zakka
20 papers · 11 as a resident
Taofeek Owonikoko
14 papers
Suresh Ramalingam
11 papers
Mehmet Bilen
10 papers
Bradley Carthon
9 papers
Mark Ulanja
9 papers
Conor Steuer
8 papers
Maria Diab
8 papers · 2 as a fellow

Clinical trials

Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer
Principal investigator · Completed · Phase 2
Emory University
2020–2023
Siltuximab and Spartalizumab in Patients With Metastatic Pancreatic Cancer
Principal investigator · Completed · Phase 1, Phase 2
Emory University
2020–2023
Niraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal Cancer
Principal investigator · Active not recruiting · Phase 2
Emory University
2019–2026
Effects on Quality of Life With Zinc Supplementation in Patients With Gastrointestinal Cancer
Principal investigator · Completed
Emory University
2019–2022